Sernova Corp. Price Target Cut to C$2.50/Share From C$3.00 by Ventum Financial

Dow Jones09/13 23:49

Sernova Corp. Is Maintained at Buy by Ventum Financial

Dow Jones09/13 23:49

Sernova Corp. Announces Appointment of New Chief Executive Officer

GlobeNewswire08/12 19:45

Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes

Stockhouse 06/25 19:00

Sernova Appoints Jonathan Rigby to Its Board of Directors

Stockhouse 05/28 19:00

Sernova Announces AGM Voting Results

Stockhouse 05/01 19:00